Thromboembolic risk of tamoxifen in patients with stage II breast cancer.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 1989
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Age Factors (MeSH)
- Breast Neoplasms (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Neoplasm Staging (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Tamoxifen (MeSH)
- Thromboembolism (MeSH)
published in
- Journal of Clinical Oncology Journal